Chief Operating Officer
Ali has more than 20 years of multidisciplinary experience as a Manager in life science innovation area acquiring a wide range of skills and expertise from operational to strategic positions in several biotech companies (ExonHit Therapeutics, Faust Pharmaceuticals, Biomethodes…). During his career, he set up various scientific (neurosciences, oncology, biomarkers, protein microarray, genomic splice variants …) to business international partnerships. With a result-oriented project and team management, he achieves assets to improve the promotion and valorisation of scientific projects. Ali was head of R&D and quality departments, business development manager and consultant, and co-founder and CEO of a start-up company dedicated to the identification of biomarkers. Ali Aït-Ikhlef holds a Ph.D. in Neurosciences from the Pierre & Marie Curie University (Paris) and did a master of corporate Management from Paris-Dauphine University (Paris).